Getting health information technology (IT) to work in one provider system can be difficult enough, but in ACOs, they have multiple systems on different platforms, explained Joseph Gifford, MD, chief executive officer of the Providence-Swedish Health Alliance.
Getting health information technology (IT) to work in one provider system can be difficult enough, but in ACOs, they have multiple systems on different platforms, explained Joseph Gifford, MD, chief executive officer of the Providence-Swedish Health Alliance.
What health IT and interoperability challenges do the Providence-Swedish Health Alliance ACOs face?
It’s a huge challenge. It’s worse than even you even might think. It’s not just how do you get Epic to work for a provider system so it works smoothly. It’s not that—that is one thing. What if you have a partnership of 5 different provider systems, each of which is on a different instance of Epic and 1 is on Centricity and you’re trying to coordinate with an employer, like Boeing, who has data sources from Blue Cross of Illinois and pharmacy from Express Scripts and enrollment data from Aeon and multiple wellness vendors, and a behavioral wellness vendor that’s carved out. And you have to take all of this information and coordinate it in a way that is actionable for the providers to give better care.
It’s a phenomenal problem. We’ll be working on that one for 20 years. So it’s like it won’t be fixed any time soon, but its time to get started. We just go one step at a time. We take information, provide reports, and just kind of work at it one step at a time.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More